|
General Information
|
|
|
Product
|
Progesterone Receptor Peptide
|
|
Description
|
Antigenic Blocking Peptide Progesterone Receptor Antibody N-epitope
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Synthetic peptide taken within amino acid region 320-370 on human Progesterone receptor protein.
|
|
Accession #
|
GenBank: AAD01587.1
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Determinant
|
N-epitope
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
P06401
|
|
Overview
|
The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Progesterone receptor isoform B (PRB) is involved activation of c-SRC/MAPK signaling on hormone stimulation.
Isoform A: inactive in stimulating c-Src/MAPK signaling on hormone stimulation.
Isoform 4: Increases mitochondrial membrane potential and cellular respiration upon stimulation by progesterone.
|
|
Molecular Function
|
DNA binding; Enzyme binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; Steriod hormone receptor activity; Transcription regulation
|
|
Subcellular Location
|
Nucleus. Cytoplasm
Note: Nucleoplasmic shuttling is both homone- and cell cycle-dependent. On hormone stimulation, retained in the cytoplasm in the G1 and G2/M phases.
Isoform A : Nucleus. Cytoplasm
Note: Mainly nuclear.
Isoform 4 : Mitochondrion outer membrane
mitochondrial outer membrane
Cytoplasm, Membrane, Mitochondrion, Mitochondrion outer membrane, Nucleus
|
|
Structure
|
Interacts with SMARD1 and UNC45A. Interacts with CUEDC2; the interaction promotes ubiquitination, decreases sumoylation, and repesses transcriptional activity. Interacts with PIAS3; the interaction promotes sumoylation of PR in a hormone-dependent manner, inhibits DNA-binding, and alters nuclear export. Interacts with SP1; the interaction requires ligand-induced phosphorylation on Ser-345 by ERK1/2 MAPK. Interacts with PRMT2.
|
|
Alternative Nomenclature
|
NR3C3 antibody
Nuclear receptor subfamily 3 group C member 3 antibody
PGR antibody
PR antibody
PR antibody
PRA antibody
PRB antibody
Progesterone receptor antibody
Progestin receptor form A antibody
Progestin receptor form B antibody
Progestin receptor form C antibody
|
| |
|
Progesterone Receptor Antibody
Progesterone Receptor Antibody FITC
Progesterone Receptor Antibody BIOTIN
Progesterone Receptor Positive Control
